Global Gene Editing Market Is Predicted to Grow Around US$ 21,008.7 Million By 2030

February 2023 | Report Format: Electronic (PDF)

The rapid expansion in the people worldwide, as well as the rising need for agriculture and animal around the world, are major drivers fuelling the development of the Gene Editing Industry. The government’s effort to promote research and improve agricultural production is helping to drive the expansion of the Gene Editing Industry. Furthermore, increasing demand for genetic information by livestock producers, as well as technical advancements in sequencing equipment such as shorter sequencing life and high machines, are propelling the development of the Gene Editing Industry.

The genome editing industry is poised for growth in emerging markets, particularly the BRICS countries, due to their rising research and development spending. Brazil, for instance, is a leader in industrial biotech research and investment, with a focus on developing new pharmaceuticals, diagnostics, vaccines, cell treatments, regenerative medicine and tissue engineering, and genetic and molecular testing. To take advantage of these trends, leading players in the genome editing market are pursuing inorganic strategies such as partnerships and collaborations to expand their presence in Brazil and other emerging markets, thereby driving market growth. Additionally, the increasing demand for synthetic genes in the development of cancer treatments is expected to significantly contribute to the growth of the genome editing market in the coming years.

North America has the biggest share of the Gene Editing Industry, while Asia-Pacific is anticipated to develop at the quickest rate during the predicted period. The U.S. government provides funding to a number of research organizations that assist in the development and production of drugs for a variety of rare genetic illnesses. For instance, research projects to enhance the area of genomics are supported by the National Human Genome Research Institute.

The NIH, National Institutes of Health, the nation's medical research organization and a division of the U.S. government's Health and Human Services, is in charge of genetics and biomedical research. The Arizona State University and Bayer College of Medicine have received funding from the NIH in the amount of USD 1.6 million for the evaluation of current developments in human genome editing. The mortality rate has dropped as a result of recently produced pharmaceuticals created expressly for the treatment of genetic abnormalities, which will accelerate the predicted future growth of the gene editing market.

Request a Free Sample Copy: Gene Editing Market Report

Gene Editing Market Report Highlights

• In June 2021, Allele Biotechnology and Alpine BioTherapeutics Corporation announced an agreement for developing induced pluripotent stem cells for the treatment of retinal diseases. This strategy assisted the company in developing an advanced product portfolio.
• In May 2020, Caribou Science entered into a commercial and clinical license agreement with MaxCyte. The agreement was aimed to gain exclusive rights to use MaxCyte's flow electroporation technology as well as ExPERT platform. This strategy advanced Caribou's gene-edited allogeneic T cell therapy programs and expanded their corporate relations in gene editing market.

GENE EDITING MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Gene Editing Technology Outlook (Revenue, USD Million, 2017 - 2030)

• Zinc Finger Nucleases (ZFNs)
• Transcription Activator-Like Effector-based Nucleases (TALENs)
• CRISPR-Cas9 Gene Editing
• Restriction Enzymes
• Others

Gene Editing Application Outlook (Revenue, USD Million, 2017 - 2030)

• Gene editing
• Cell Line Engineering
• Animal Genetic Engineering
• Plant Genetic Engineering
• Drug development
• Others

Gene Editing End User Outlook (Revenue, USD Million, 2017 - 2030)

• Biotechnology and Pharmaceutical Companies
• Academic and Government Research Institutes
• Contract Research Organizations

Gene Editing Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America (U.S., and Canada)
• Europe (Germany, U.K., France, Italy, Spain etc.)
• Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
• South America (Brazil, Mexico, Argentina etc.)
• Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

 List of Key Players- Gene Editing Market

• Addgene
• Allele Biotech
• Bio-Rad
• Takara Bio
• CRISPR Therapeutics
• OriGene Technologies
• Precision Biosciences
• GE Healthcare
• Merck KGaA
• ThermoFischer Scientific Inc.

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

76 Kennington Road,

London SE11 6NL,

United Kingdom

USA Phone: +1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/